FDA Advisory Panel To Evaluate Computer-Assisted Orthopedic Devices
The use of radiologic and other intraoperative assessments as surrogate endpoints for computer-assisted surgical technologies in orthopedic use will be discussed by FDA's Orthopedics and Rehabilitation Devices advisory committee at its November 4 meeting, according to an agency memo issued to panel members.
More from Archive
More from Medtech Insight
SAGA Diagnostics has launched its breast cancer residual and recurrence detection test – Pathlight – in the US. The test’s ultrahigh sensitivity and specificity is rare to see in oncology, the company claimed.
The imaging, Varian, and advanced therapies segments – which are more reliant on equipment sales – are more heavily affected, with tariffs applying to roughly 55% of their revenue base. In diagnostics, the company expects minimal exposure due to sufficient US value-added manufacturing.
The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.